Avicanna (TSX:AVCN) Change In Inventory : C$1.20 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Avicanna Change In Inventory?

Avicanna's change in inventory for the quarter that ended in Dec. 2023 was C$1.09 Mil. It means Avicanna's inventory declined by C$1.09 Mil from Sep. 2023 to Dec. 2023 .

Avicanna's change in inventory for the fiscal year that ended in Dec. 2023 was C$1.20 Mil. It means Avicanna's inventory declined by C$1.20 Mil from Dec. 2022 to Dec. 2023 .

Avicanna's Total Inventories for the quarter that ended in Dec. 2023 was C$4.54 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Avicanna's Days Inventory for the quarter that ended in Dec. 2023 was 107.57.

Inventory Turnover measures how fast the company turns over its inventory within a year. Avicanna's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.85.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Avicanna's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.84.

Avicanna Change In Inventory Historical Data

The historical data trend for Avicanna's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avicanna Change In Inventory Chart

Avicanna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-1.51

-0.33

-2.16

0.87

1.20

Avicanna Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															2.40	-0.20	-1.76	2.07	1.09

Avicanna Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.20 Mil.

Avicanna (TSX:AVCN) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Avicanna's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	5.109	/	4.334	*	365 / 4
	=	107.57

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Avicanna's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	4.334	/	5.109
	=	0.85

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Avicanna's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	5.109	/	6.053
	=	0.84

Avicanna Change In Inventory Related Terms

Thank you for viewing the detailed overview of Avicanna's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Avicanna (TSX:AVCN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (TSX:AVCN) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

AVCNF:USA 0NN:Germany

Address

480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2

Website

https://www.avicanna.com

Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.

Executives

Sheldon Inwentash

10% Security Holder

Avicanna (TSX:AVCN) Headlines

No Headlines